bioRxivBiochemistry
Molecular Bases of the Membrane Association Mechanism Potentiating Antibiotic Resistance by New Delhi Metallo--Lactamase 1
A. Prunotto, G. Bahr, L. J. Gonzalez, A. J. Vila, M. Dal Peraro
Abstract
Resistance to last-resort carbapenem antibiotics is an increasing threat to human health, as it critically limits therapeutic options. Metallo-{beta}-lactamases are the largest family of carbapenemases, enzymes that inactivate these drugs. Among MBLs, New Delhi metallo-{beta}-lactamase 1 has experienced the fastest and largest worldwide dissemination. This success has been attributed to the fact that NDM-1 is a lipidated protein anchored to the outer membrane of bacteria, while all other MBLs are soluble periplasmic enzymes. By means of a combined experimental and computational approach, we show that NDM-1 interacts with the surface of bacterial membranes in a stable, defined conformation, in which the active site is not occluded by the bilayer. Although the lipidation is required for a long-lasting interaction, the globular domain of NDM-1 is tuned to interact specifically with the outer bacterial membrane. In contrast, this affinity is not observed for VIM-2, a natively soluble MBL. Finally, we identify key residues involved in the membrane interaction of NDM-1, which constitute potential targets for developing therapeutic strategies able to combat resistance granted by this enzyme.
- assay: proteomics
- research focus: protein folding & dynamics
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Allosteric Inhibition of NDM-1 by Thanatin Preserves the Di-Zinc Center While Restricting Dynamics
Gwladys Rivière, Prince Kumar, … Leonard J. Mueller·bioRxiv·Feb 27, 2026
- Novel MBLs inhibitors screened from FDA-approved drug library restore the susceptibility of carbapenems to NDM-1-harbouring bacteria
- Identification of potential carboxylic acid-containing drug candidate to design novel competitive NDM inhibitors: An in-silico approach comprising combined virtual screening and molecular dynamics simulation
Karthick Vasudevan, Soumya Basu, … Balaji Veeraraghavan·bioRxiv·Jul 5, 2021
- Insight into the mechanism of molecular interactions of the NDM metallo-beta-lactamase and cyclic boronate inhibition by molecular docking and molecular dynamics simulations
Yi Shi·bioRxiv·Sep 15, 2026
- Adaptive landscape of the metallo-β-lactamase NDM to emerging β-lactam-based therapies
Fernanda Durán Romero, Salvador I. Drusin, … Alejandro J. Vila·bioRxiv·Jul 13, 2026
- Covalent Inhibition of New Delhi Metallo-β-Lactamases NDM-1 and NDM-5 by 3-Bromopyruvate
Jack K. Bradley, Karina Calvopiña, … Adam Paul Roberts·JAC-Antimicrobial ResistancePeer-reviewed·Jul 2, 2026